Apatinib With Albumin-bound Paclitaxel in Patients With Platinum-resistant Recurrent Ovarian Cancer

NCT03942068 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

35

Enrollment

OTHER_GOV

Sponsor class

Conditions

Ovarian Cancer

Interventions

DRUG: albumin-bound paclitaxel
DRUG: Apatinib

Sponsor

Henan Cancer Hospital